Jing Wang

Key Laboratory of Material Physics Ministry of Education School of Physics and Microelectronics Zhengzhou University

关注

立即认领

关注

立即认领

基本信息

浏览量：13

职业迁徙

个人简介

Jing Wang received the B.S. degree in information engineering from Henan Normal University, Xinxiang, China, in 2015, and the M.S. degree from Zhengzhou University, Zhengzhou, China, in 2018, where she is currently pursuing the Ph.D. degree in software engineering. Her research interests include image processing and data mining.

研究兴趣

论文共 65 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

时间

引用量

主题

期刊级别

合作者

合作机构

Regulation of Immune Microenvironments by Polyetheretherketone Surface Topography for Improving Osseointegration

Yuqing Zhao,Yanxin An, Fan Wu, Lipeng Liu,Franklin R. Tay,Yang Jiao,Jing Wang

Journal of Nanobiotechnologyno. 1 (2025): 1-22

引用0浏览0WOS引用

Strategies for Promoting Neurovascularization in Bone Regeneration

Xin-Ling Li, Yu-Qing Zhao, Li Miao,Yan-Xin An, Fan Wu, Jin-Yu Han, Jing-Yuan Han,Franklin R. Tay,Zhao Mu,Yang Jiao,Jing Wang

Military Medical Research（2025）

引用0浏览0WOS引用

An Efficient Multi-View and Multi-Channel Disease Risk Prediction Model

Zhan Wang,Runzhi Li,Jing Wang,Hongling Zhao,Siyu Yan,Lihong Ma

2023 International Conference on Cyber-Physical Social Intelligence (ICCSI)pp.144-149, (2023)

引用0浏览0EIWOS引用

611P SHR-1701 in Combination with BP102 and XELOX As First-Line (1L) Treatment for Patients (pts) with Unresectable Metastatic Colorectal Cancer (mcrc): Data from a Phase II/III Study

R-H. Xu,M. Qiu,Y. Bai,J. Wang,K. Gu,M. Yang, Y. He,C. Yi, Y. Jin, B. Liu, F. Wang,C. Huang, Y. Jiang

Annals of Oncology（2023）

引用1浏览0引用

Mortality Trend Analysis of Ischemic Heart Disease in China Between 2010 and 2019: a Joinpoint Analysis

Xiaoli Fu,Jing Wang,Shuai Jiang,Jian Wu,Zihan Mu,Yanyu Tang,Suxian Wang,Hang Fu,He Ma,Yaojun Zhao

BMC PUBLIC HEALTH（2023）

引用5浏览0引用

Multi-view Feature Representation and Fusion for Drug-Drug Interactions Prediction

Jing Wang,Shuo Zhang,Runzhi Li,Gang Chen,Siyu Yan,Lihong Ma

BMC BIOINFORMATICS（2023）

引用6浏览0WOSEI引用

636P Combination Therapy of Envafolimab, Suvemcitug, and FOLFIRI in Patients with Metastatic Microsatellite Stable (MSS) or Mismatch-Repair Proficient (pmmr) Colorectal Cancer: Results from a Phase II Clinical Trial

Y. Liu,J. Wang,Y. Fang,Y. Deng,C. Hu,Q. Fan,K. Gu, Y. Zhang,C. Yang, J. Tian, Z. Liu, X. Sun, S. Sun,Y. Cheng

Annals of Oncology（2023）

引用0浏览0引用

SHR-1701 in Combination with BP102 and XELOX As First-Line (1L) Treatment for Patients (pts) with Unresectable Metastatic Colorectal Cancer (mcrc): Data from a Phase II/III Study

R-H. Xu,M. Qiu,Y. Bai,J. Wang,K. Gu,M. Yang, Y. He,C. Yi, Y. Jin, B. Liu, F. Wang,C. Huang, Y. Jiang

ANNALS OF ONCOLOGY (2023): S439-S439

引用0浏览0引用

Trends in All-Cause Mortality and Leading Causes of Death from 2009 to 2019 among Older Adults in China

Jian Wu,Zihan Mu,Shuai Jiang,Yudong Miao,Yanyu Tang,Jing Wang,Suxian Wang,Yaojun Zhao

BMC Geriatricsno. 1 (2023)

引用1浏览0WOS引用

GEMSTONE-303: Prespecified Progression-Free Survival (PFS) and Overall Survival (OS) Final Analyses of a Phase III Study of Sugemalimab Plus Chemotherapy Vs Placebo Plus Chemotherapy in Treatment-Naive Advanced Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma

X. Zhang,J. Wang, G. Wang,Y. Zhang,Q. Fan, L. Chuangxin,C. Hu, M. L. Sun, Y. Wan,S. Sun, L. Zhang,Y. Shu, J. Luo, D. Zhu, H. Wang, Y. Xu, Q. Shi,J. J. Yang,L. Shen

ANNALS OF ONCOLOGY (2023): S1319-S1319

引用0浏览0引用

加载更多

作者统计

#Papers: 65

#Citation: 976

H-Index: 17

G-Index: 29

Sociability: 6

Diversity: 3

Activity: 22

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn